另一个偏头痛基因.

Same author

Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent.

Signal transduction and targeted therapy·2026

Same author

UCL Queen Square Institute of Neurology: 75 years of innovation.

The Lancet. Neurology·2026

Same author

Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study.

Annals of neurology·2025

Same author

Deciphering temporal gene expression dynamics during epilepsy development using a rat model of focal neocortical epilepsy.

Epilepsia·2024

Same author

Early developmental alterations of CA1 pyramidal cells in Dravet syndrome.

Neurobiology of disease·2024

Same author

Structure-function and pharmacologic aspects of ion channels relevant to neurologic channelopathies.

Handbook of clinical neurology·2024

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

另一个偏头痛基因.

相关概念视频

Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent.

UCL Queen Square Institute of Neurology: 75 years of innovation.

Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study.

Deciphering temporal gene expression dynamics during epilepsy development using a rat model of focal neocortical epilepsy.

Early developmental alterations of CA1 pyramidal cells in Dravet syndrome.

Structure-function and pharmacologic aspects of ion channels relevant to neurologic channelopathies.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

另一个偏头痛基因.

相关概念视频

相关文章

Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent.

UCL Queen Square Institute of Neurology: 75 years of innovation.

Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study.

Deciphering temporal gene expression dynamics during epilepsy development using a rat model of focal neocortical epilepsy.

Early developmental alterations of CA1 pyramidal cells in Dravet syndrome.

Structure-function and pharmacologic aspects of ion channels relevant to neurologic channelopathies.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.